iNCOVACC (ChAd36-SARS-CoV-S COVID-19 vaccine (recombinant))
/ Bharat Biotech, Washington University School of Medicine in St. Louis
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
54
Go to page
1
2
3
July 31, 2024
Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters.
(PubMed, Sci Adv)
- "In contrast, sequential transmission occurred after systemic immunization with the mRNA vaccine. Thus, immunization with a mucosal COVID-19 vaccine protects against cycles of respiratory transmission of SARS-CoV-2 and can potentially limit the community spread of the virus."
Journal • Preclinical • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
February 10, 2024
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
(PubMed, Nat Immunol)
- "A nasally delivered chimpanzee adenoviral-vectored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is currently used in India (iNCOVACC)...However, depletion of memory CD8+ T cells before XBB.1.5 challenge resulted in loss of protection against upper and lower respiratory tract infection. Thus, nasally delivered vaccines stimulate mucosal immunity against emerging SARS-CoV-2 strains, and cross-reactive memory CD8+ T cells mediate protection against lung infection by antigenically distant strains in the setting of low serum levels of cross-reactive neutralizing antibodies."
Journal • Infectious Disease • Novel Coronavirus Disease • Otorhinolaryngology • Respiratory Diseases • CD8
August 19, 2023
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin).
(PubMed, NPJ Vaccines)
- P3 | "Both vaccines were well tolerated. Overall reported solicited reactions were 6.9% and 25.5% and unsolicited reactions were 1.2% and 3.1% in BBV154 and Covaxin participants respectively."
Journal • P3 data • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
June 22, 2023
"hopeful for #covaxin or #incovacc"
(@dvmknnth)
June 01, 2023
"And hopefully @BARDA will consider supporting @Ocugen for both covaxin and Incovacc. We shouldn’t limit ourselves."
(@Dfwmb123)
May 25, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @RickABright @WHCOVIDResponse #bharatbiotech #ocugen #OCU500"
(@Diego48979433)
Novel Coronavirus Disease
May 25, 2023
"Let me guess, PFE or Moderna must not have a next gen nasal vaccines yet #BuyingTime Meanwhile #iNCOVACC #Covaxin are ready"
(@doc_holliday50)
Clinical
May 19, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #bharatbiotech #ocugen #OCU500"
(@Diego48979433)
Novel Coronavirus Disease
May 15, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #bharatbiotech #ocugen #OCU500"
(@Diego48979433)
Novel Coronavirus Disease
May 08, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
April 14, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
April 11, 2023
"#iNCOVACC and #Covaxin"
(@doc_holliday50)
April 05, 2023
"#COVAXIN #INCOVACC @NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
March 24, 2023
"#covaxin #incovacc"
(@NathanR91334798)
March 23, 2023
"@Ocugen just pay the fee like @moderna_tx and @pfizer if not will never see covaxin or incovacc in the United States @NIH @US_FDA @CDCgov = PAY TO PLAY."
(@NathanR91334798)
March 20, 2023
"@NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #covaxin #incovacc #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
March 14, 2023
"Approve Covaxin and incovacc. They may be the one way out of this mess."
(@Dfwmb123)
March 14, 2023
"#IchooseCOVAXIN #INCOVACC #Ocugen #BharatBiotech #IRefusemRNA"
(@CraigGordon8)
March 09, 2023
"@NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #covaxin #incovacc #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
March 04, 2023
"@NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @WHCOVIDResponse #covaxin #incovacc #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
February 23, 2023
"@NIHDirector @HHSGov @DrCaliff_FDA @CDCDirector @AshishKJha46 @elonmusk @WHCOVIDResponse #covaxin #incovacc #bharatbiotech #ocugen"
(@Diego48979433)
Novel Coronavirus Disease
February 14, 2023
"Let’s get covaxin and incovacc avail world."
(@Dfwmb123)
February 09, 2023
"@US_FDA @FDA_Drug_Info @DrCaliff_FDA #COVAXIN and #INCOVACC would be great for the people @Ocugen @BharatBiotech"
(@nrbarile)
Clinical
February 02, 2023
"You should really look into #COVAXIN #INCOVACC #ocugen #bharatbiotech"
(@Wetsu25)
January 24, 2023
"Approve #covaxin and #incovacc"
(@Gustavo74001799)
1 to 25
Of
54
Go to page
1
2
3